KATHERINE MOORE: Open Payments
NPI 1730818089 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $1,559
Food & beverage: $1,556Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $259 |
| Galderma Laboratories, L.P. | 3 | $219 |
| Lilly USA, LLC | 3 | $215 |
| Janssen Biotech, Inc. | 1 | $145 |
| Botanix SB Inc | 1 | $137 |
| UCB, Inc. | 1 | $125 |
| Organon LLC | 1 | $125 |
| LEO Pharma Inc. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
| PFIZER INC. | 1 | $99 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, SOFDRA, EBGLYSS, Bimzelx, VTAMA, ANZUPGO.
Industry payments across VA — which companies pay providers there.
